PNC Financial Services Group Inc. lowered its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA – Free Report) by 38.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 544 shares of the company’s stock after selling 337 shares during the quarter. PNC Financial Services Group Inc.’s holdings in USANA Health Sciences were worth $29,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Quest Partners LLC purchased a new stake in shares of USANA Health Sciences during the fourth quarter worth about $66,000. CWM LLC grew its position in shares of USANA Health Sciences by 49.6% during the fourth quarter. CWM LLC now owns 1,267 shares of the company’s stock worth $68,000 after purchasing an additional 420 shares in the last quarter. Trexquant Investment LP purchased a new position in USANA Health Sciences during the 4th quarter valued at approximately $266,000. Louisiana State Employees Retirement System purchased a new position in USANA Health Sciences during the 4th quarter valued at approximately $300,000. Finally, Summit Global Investments purchased a new position in USANA Health Sciences during the 4th quarter valued at approximately $307,000. Hedge funds and other institutional investors own 54.25% of the company’s stock.
USANA Health Sciences Price Performance
NYSE USNA opened at $44.45 on Tuesday. The stock has a market capitalization of $846.77 million, a PE ratio of 13.85, a P/E/G ratio of 1.32 and a beta of 0.90. The business has a 50 day simple moving average of $46.37 and a two-hundred day simple moving average of $47.67. USANA Health Sciences, Inc. has a 1-year low of $41.45 and a 1-year high of $69.60.
USANA Health Sciences (NYSE:USNA – Get Free Report) last released its quarterly earnings results on Tuesday, April 30th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.17. The business had revenue of $227.80 million during the quarter, compared to analysts’ expectations of $223.27 million. USANA Health Sciences had a return on equity of 12.80% and a net margin of 6.88%. On average, analysts anticipate that USANA Health Sciences, Inc. will post 2.78 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Separately, DA Davidson cut their price target on USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating for the company in a report on Tuesday, May 7th.
Check Out Our Latest Stock Report on USANA Health Sciences
Insider Activity
In other news, major shareholder Myron W. Wentz sold 13,496 shares of the firm’s stock in a transaction that occurred on Friday, June 14th. The stock was sold at an average price of $45.03, for a total value of $607,724.88. Following the completion of the sale, the insider now directly owns 7,864,345 shares of the company’s stock, valued at approximately $354,131,455.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, major shareholder Myron W. Wentz sold 13,496 shares of the firm’s stock in a transaction that occurred on Friday, June 14th. The stock was sold at an average price of $45.03, for a total transaction of $607,724.88. Following the completion of the sale, the insider now directly owns 7,864,345 shares of the company’s stock, valued at approximately $354,131,455.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Daniel A. Macuga sold 3,791 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $47.14, for a total value of $178,707.74. The disclosure for this sale can be found here. Insiders sold 31,591 shares of company stock valued at $1,458,098 in the last ninety days. Insiders own 0.33% of the company’s stock.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Featured Stories
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA – Free Report).
Receive News & Ratings for USANA Health Sciences Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for USANA Health Sciences and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
